The area under the diagnosis curve of HSP90α against lung cancer is 0.857, sensitivity is 93.10%, and specificity is 62.5%, and thus HSP90α is anticipated to become a tumour biomarker for lung cancer diagnosis. Here, HSP90AA1 is linked to lung carcinoma.